United States
Germany
Japan
United Kingdom
China
MXI1 (NM_001008541) Human Tagged ORF Clone Lentiviral Particle
CAT＃: RC202332L3V
- LentiORF®
-
Lenti ORF particles, MXI1 (Myc-DDK tagged) - Human MAX interactor 1 (MXI1), transcript variant 3, 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 7,410.00
货期*
详询
规格
Product images
经常一起买 (3)
Specifications
| Product Data | |
| Product Name | MXI1 (NM_001008541) Human Tagged ORF Clone Lentiviral Particle |
| Synonyms | bHLHc11; MAD2; MXD2; MXI |
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| ACCN | NM_001008541 |
| ORF Size | 546 bp |
| Sequence Data |
The ORF insert of this clone is exactly the same as(RC202332).
|
| OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
| OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
| Reference Data | |
| RefSeq | NM_001008541.1, NP_001008541.1 |
| RefSeq Size | 3047 bp |
| RefSeq ORF | 549 bp |
| Locus ID | 4601 |
| Protein Families | Druggable Genome, Transcription Factors |
| MW | 20.6 kDa |
| Gene Summary | Expression of the c-myc gene, which produces an oncogenic transcription factor, is tightly regulated in normal cells but is frequently deregulated in human cancers. The protein encoded by this gene is a transcriptional repressor thought to negatively regulate MYC function, and is therefore a potential tumor suppressor. This protein inhibits the transcriptional activity of MYC by competing for MAX, another basic helix-loop-helix protein that binds to MYC and is required for its function. Defects in this gene are frequently found in patients with prostate tumors. Three alternatively spliced transcripts encoding different isoforms have been described. Additional alternatively spliced transcripts may exist but the products of these transcripts have not been verified experimentally. [provided by RefSeq, Jul 2008] |
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
You may also need
Customer
Reviews
Loading...
